Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v3-FR
Language English French
Date Updated 2021-11-05 2021-10-14
Drug Identification Number 02485540 02485540
Brand name HYDROMORPHONE HYDROCHLORIDE INJECTION USP HYDROMORPHONE HYDROCHLORIDE INJECTION USP
Common or Proper name Hydromorphone Hydrochloride Injection USP Hydromorphone Hydrochloride Injection USP
Company Name STERINOVA INC. STERINOVA INC.
Ingredients HYDROMORPHONE HYDROCHLORIDE HYDROMORPHONE HYDROCHLORIDE
Strength(s) 40MG 40MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 30 x 100 mL 30 x 100 mL
ATC code N02AA N02AA
ATC description OPIOIDS OPIOIDS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2021-10-15 2021-10-15
Actual start date 2021-10-15 2021-10-15
Estimated end date 2021-11-05 2021-11-05
Actual end date 2021-11-04
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Alternative format of Hydromorphone Hydrochloride Injection USP, 20 mg/ 50 mL available.
Health Canada comments